Insiders · Profile

Sullivan Mark

Chief Legal Officer at Definium Therapeutics. Filing since 25 Jun 2024. CIK 0001331843

Company

Date

Role

Action

Shares

Amount

Of holding

DFTX Definium Therapeutics, Inc.

25 Sep 2026

Chief Legal Officer

Sold on a plan

14,051

$513.85K

2.8%

DFTX Definium Therapeutics, Inc.

25 Jun 2026

Chief Legal Officer

Sold on a plan

13,008

$585.75K

3.9%

DFTX Definium Therapeutics, Inc.

25 Mar 2026

Chief Legal Officer

Sold on a plan

10,702

$197.67K

3.8%

DFTX Definium Therapeutics, Inc.

26 Dec 2025

Chief Legal Officer

Sold on a plan

11,276

$148.24K

3.8%

DFTX Definium Therapeutics, Inc.

25 Sep 2025

Chief Legal Officer

Sold on a plan

11,278

$110.19K

3.7%

DFTX Definium Therapeutics, Inc.

25 Jun 2025

Chief Legal Officer

Sold on a plan

11,491

$78.14K

3.6%

DFTX Definium Therapeutics, Inc.

25 Mar 2025

Chief Legal Officer

Sold on a plan

6,576

$44.32K

2.0%

DFTX Definium Therapeutics, Inc.

26 Dec 2024

Chief Legal Officer

Sold on a plan

4,519

$33.58K

2.5%

DFTX Definium Therapeutics, Inc.

25 Sep 2024

Chief Legal Officer

Sold on a plan

4,430

$26.49K

2.4%

DFTX Definium Therapeutics, Inc.

25 Jun 2024

Chief Legal Officer

Sold on a plan

17,854

$128.91K

8.9%

10 decisions on file.